Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced its unaudited interim financial results on Thursday for the third quarter ending Sept. 30, 2024.
“Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said. "Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.”
The company said that it's seeing significant demand for its flower internationally as it continues to integrate AgMedica.
Decibel closed the acquisition of AgMedica Bioscience Ltd. in October. The transaction was arranged through an agreement with Callisto Capital Corp. and was made in exchange for a $6.3 million unsecured convertible debenture.
Read Next:
Decibel's shares traded 5.54% higher at $0.0495 per share after the market close on Thursday afternoon.